Robert Saller
Impact in
- Biotechnology top 10%
- Cancer Research and Treatments
-
- Virus-based gene therapy research
Papers in
-
- CRISPR and Genetic Engineering 6
- RNA Interference and Gene Delivery 5
- Renal and related cancers 4
- Viral Infectious Diseases and Gene Expression in Insects 4
- Genetics 11
- Virus-based gene therapy research 9
- Animal Genetics and Reproduction 3
- Co-authors
- Brian Salmons (17 shared papers)Walter H. Günzburg (11 shared papers)Matthias Löhr (8 shared papers)Marc Piechaczyk (3 shared papers)Mireia Pelegrín (3 shared papers)Peter Karle (6 shared papers)Petra Müller (3 shared papers)Danièle Noël (2 shared papers)
- Journals
- Annals of the New York Academy of Sciences (3 papers)Cancer Gene Therapy (2 papers)The Journal of Gene Medicine (2 papers)Human Gene Therapy (1 paper)Biologicals (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Robert Saller
25 papers receiving 394 citations
Peers
Comparison fields: 5 of 62
- Biotechnology 61
- Genetics 140
- Biomaterials 55
- Oncology 100
- Surgery 155
Countries citing papers authored by Robert Saller
This map shows the geographic impact of Robert Saller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Saller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Saller more than expected).
Fields of papers citing papers by Robert Saller
This network shows the impact of papers produced by Robert Saller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Saller. The network helps show where Robert Saller may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Saller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 82 | |
| 2 | 1998 | 45 | |
| 3 | 2002 | 27 | |
| 4 | 2000 | 27 | |
| 5 | 1998 | 25 | |
| 6 | 1999 | 23 | |
| 7 | 2000 | 20 | |
| 8 | Construction of retroviral vectors for targeted delivery and expression of therapeutic genes. | 1995 | 18 |
| 9 | Retroviral vector targeting for gene therapy. | 1996 | 16 |
| 10 | Encapsulated cells producing retroviral vectors for in vivo gene transfer. | 2002 | 15 |
| 11 | 2005 | 14 | |
| 12 | 1998 | 14 | |
| 13 | 1999 | 12 | |
| 14 | 2002 | 11 | |
| 15 | Quantitative distinction of cisplatin-sensitive and -resistant mouse fibrosarcoma cells grown in multicell tumor spheroids. | 1995 | 10 |
| 16 | 2002 | 10 | |
| 17 | 1995 | 9 | |
| 18 | 2002 | 8 | |
| 19 | 2001 | 6 | |
| 20 | 2004 | 6 |
About Robert Saller
Robert Saller is a scholar working on Molecular Biology, Genetics, Oncology, Surgery and Biotechnology, having authored 25 papers that have together received 407 indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), Cancer Cells and Metastasis (6 papers), CRISPR and Genetic Engineering (6 papers), Pancreatic function and diabetes (5 papers), RNA Interference and Gene Delivery (5 papers), Renal and related cancers (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Animal Genetics and Reproduction (3 papers). The work is most often cited by research in Biotechnology (61 citations), Genetics (140 citations), Biomaterials (55 citations), Oncology (100 citations) and Surgery (155 citations). Robert Saller has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Brian Salmons, Walter H. Günzburg, Matthias Löhr, Marc Piechaczyk, Mireia Pelegrín, Peter Karle, Petra Müller, Danièle Noël, Jan Stange and Ralf Jesnowski. Their work appears in journals such as Annals of the New York Academy of Sciences, Cancer Gene Therapy, The Journal of Gene Medicine, Human Gene Therapy and Biologicals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.